QI
VRTX icon

Qtron Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Qtron Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$668K Sell
1,344
-1,258
-48% -$558K 0.09% 262
2026
Q1 		$1.16M Hold
2,602
– – 0.16% 155
2025
Q4 		$1.18M Buy
2,602
+728
+39% +$314K 0.15% 149
2025
Q3 		$734K Sell
1,874
-142
-7% -$59.3K 0.09% 255
2025
Q2 		$898K Hold
2,016
– – 0.11% 211
2025
Q1 		$977K Hold
2,016
– – 0.15% 176
2024
Q4 		$812K Sell
2,016
-1,115
-36% -$517K 0.11% 232
2024
Q3 		$1.46M Sell
3,131
-1,600
-34% -$769K 0.2% 116
2024
Q2 		$2.22M Buy
4,731
+1,003
+27% +$435K 0.32% 51
2024
Q1 		$1.56M Sell
3,728
-73
-2% -$30.9K 0.22% 97
2023
Q4 		$1.55M Sell
3,801
-220
-5% -$81.3K 0.25% 78
2023
Q3 		$1.4M Buy
4,021
+566
+16% +$198K 0.27% 75
2023
Q2 		$1.22M Hold
3,455
– – 0.23% 103
2023
Q1 		$1.09M Sell
3,455
-310
-8% -$93K 0.22% 106
2022
Q4 		$1.09M Hold
3,765
– – 0.23% 105
2022
Q3 		$1.09M Hold
3,765
– – 0.27% 90
2022
Q2 		$1.06M Hold
3,765
– – 0.23% 108
2022
Q1 		$983K Buy
+3,765
New +$894K 0.22% 126
2021
Q2 		– Sell
-933
Closed -$200K – 386
2021
Q1 		$200K Sell
933
-1,692
-64% -$372K 0.06% 324
2020
Q4 		$620K Hold
2,625
– – 0.17% 153
2020
Q3 		$714K Sell
2,625
-207
-7% -$57.1K 0.25% 87
2020
Q2 		$822K Buy
2,832
+579
+26% +$157K 0.33% 67
2020
Q1 		$536K Buy
+2,253
New +$517K 0.32% 104

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Qtron Investments's VRTX Position: Q2 2026 in Review

Qtron Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 48% in Q2 2026, selling an estimated $558K and leaving 1,344 shares worth $668K. The position accounts for 0.09% of the portfolio, ranked #262.

Qtron Investments first reported a position in VRTX in Q1 2020 and has held it in 23 quarters since. The position peaked at $2.22M in Q2 2024. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Qtron Investments held 1,344 shares of Vertex Pharmaceuticals worth $668K as of Q2 2026.
  • Qtron Investments sold 1,258 Vertex Pharmaceuticals shares in Q2 2026, an estimated $558K.
  • Vertex Pharmaceuticals made up 0.09% of Qtron Investments's portfolio in Q2 2026, its #262 holding.
  • Qtron Investments first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 23 quarters since.
  • Qtron Investments's Vertex Pharmaceuticals position peaked at $2.22M in Q2 2024.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.